Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs geared toward growing the horizons of cytokine-based immunotherapy, especially for cancers where cure alternatives remain limited. Make use of the links below to learn much more about our portfolio of cytokine-based